PRMT1 and metabolic dysfunction-associated steatotic liver disease: Additionally, emerging research has begun to elucidate the potential role of PRMT1 in chronic liver diseases (CLDs), such as nonalcoholic fatty liver disease (NAFLD) [17], neurodegenerative diseases (NDs) including Parkinson's disease (PD) [18], and immune‐related diseases [19].